Supriya Lifescience Share Price
Start SIP in Supriya Lifescience
Start SIPSupriya Lifescience Performance
Day Range
- Low 624
- High 661
52 Week Range
- Low 235
- High 675
- Open Price650
- Previous Close647
- Volume472595
Supriya Lifescience Investment Rating
-
Master Rating:
-
Supriya Lifescience has an operating revenue of Rs. 598.98 Cr. on a trailing 12-month basis. An annual revenue growth of 24% is outstanding, Pre-tax margin of 29% is great, ROE of 14% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 29% and 64% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 68 which is a FAIR score but needs to improve its earnings, a RS Rating of 89 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 105 indicates it belongs to a poor industry group of Medical-Supplies and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 161 | 158 | 140 | 140 | 132 | 142 |
| Operating Expenses Qtr Cr | 98 | 103 | 99 | 108 | 88 | 87 |
| Operating Profit Qtr Cr | 63 | 56 | 41 | 32 | 44 | 55 |
| Depreciation Qtr Cr | 5 | 4 | 4 | 4 | 4 | 3 |
| Interest Qtr Cr | 0 | 1 | 0 | 0 | 1 | 1 |
| Tax Qtr Cr | 15 | 16 | 10 | 6 | 14 | 15 |
| Net Profit Qtr Cr | 45 | 37 | 30 | 24 | 29 | 38 |
Supriya Lifescience Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹580.39
- 50 Day
- ₹513.78
- 100 Day
- ₹457.76
- 200 Day
- ₹401.52
- 20 Day
- ₹581.60
- 50 Day
- ₹488.00
- 100 Day
- ₹435.55
- 200 Day
- ₹381.33
Supriya Lifescience Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 654.68 |
| Second Resistance | 676.27 |
| Third Resistance | 691.53 |
| RSI | 72.06 |
| MFI | 77.95 |
| MACD Single Line | 39.81 |
| MACD | 41.60 |
| Support | |
|---|---|
| First Support | 617.83 |
| Second Support | 602.57 |
| Third Supoort | 580.98 |
Supriya Lifescience Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 489,570 | 26,632,608 | 54.4 |
| Week | 576,379 | 29,256,978 | 50.76 |
| 1 Month | 531,825 | 24,549,038 | 46.16 |
| 6 Month | 508,697 | 20,220,699 | 39.75 |
Supriya Lifescience Result Highlights
Supriya Lifescience Synopsis
NSE-Medical-Supplies
Supriya Lifescience is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 570.37 Cr. and Equity Capital is Rs. 16.10 Cr. for the Year ended 31/03/2024. Supriya Lifescience Ltd. is a Public Limited Listed company incorporated on 26/03/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH2008PLC180452 and registration number is 180452.| Market Cap | 5,206 |
| Sales | 599 |
| Shares in Float | 2.58 |
| No of funds | 44 |
| Yield | 0.12 |
| Book Value | 6.39 |
| U/D Vol ratio | 3.9 |
| LTDebt / Equity | |
| Alpha | 0.23 |
| Beta | 1.06 |
Supriya Lifescience Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 68.3% | 68.3% | 68.3% | 68.3% |
| Mutual Funds | 0.13% | 0.05% | 0.04% | 1.74% |
| Insurance Companies | 3.82% | 3.71% | 3.81% | 3.89% |
| Foreign Portfolio Investors | 4.95% | 5.37% | 4.56% | 5.35% |
| Individual Investors | 17.19% | 17.06% | 17.51% | 16.1% |
| Others | 5.61% | 5.51% | 5.78% | 4.62% |
Supriya Lifescience Management
| Name | Designation |
|---|---|
| Mr. Satish Waman Wagh | Exe.Chairman & W T D |
| Ms. Smita Satish Wagh | Whole Time Director |
| Ms. Saloni Satish Wagh | Whole Time Director |
| Ms. Shivani Satish Wagh | Whole Time Director |
| Mr. Balasahab Gulabrao Sawant | Whole Time Director |
| Mr. Kedar Shankar Karmarkar | Independent Director |
| Mr. Bhairav Manojbhai Chokshi | Independent Director |
| Mr. Dileep Kumar Jain | Independent Director |
| Mr. Dinesh Navnitlal Modi | Independent Director |
| Ms. Neelam Yashpal Arora | Independent Director |
Supriya Lifescience Forecast
Price Estimates
Supriya Lifescience Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-10 | Quarterly Results | |
| 2024-05-28 | Audited Results & Final Dividend | |
| 2024-02-07 | Quarterly Results | |
| 2023-11-07 | Quarterly Results | |
| 2023-08-03 | Quarterly Results |
Supriya Lifescience FAQs
What is Share Price of Supriya Lifescience ?
Supriya Lifescience share price is ₹633 As on 18 September, 2024 | 02:32
What is the Market Cap of Supriya Lifescience ?
The Market Cap of Supriya Lifescience is ₹5095.4 Cr As on 18 September, 2024 | 02:32
What is the P/E ratio of Supriya Lifescience ?
The P/E ratio of Supriya Lifescience is 37.7 As on 18 September, 2024 | 02:32
What is the PB ratio of Supriya Lifescience ?
The PB ratio of Supriya Lifescience is 6.2 As on 18 September, 2024 | 02:32